Clik here to view.
Is There a Smart Way to Use the New Oncotype Prostate Cancer Test?
On May 8th, the makers of the oncotype DX Prostate Cancer Test presented results of a large study demonstrating that their test can help men decide whether their prostate cancer carries a low enough...
View ArticleClik here to view.
What Mammograms Teach Us About Wildfires, Floods, and Tornadoes
In the wake of the horrific floods that struck Colorado recently, many people have debated whether global warming is to blame. The same goes for wildfires that hit that state this summer and for the...
View ArticleClik here to view.
You Thought Innovation Was Hard, How about De-Innovation?
David Asch and I recently published an article in Health Affairs on the challenge of getting healthcare practitioners to stop doing things they are accustomed to doing, even when the evidence that...
View ArticleClik here to view.
Which Cancers Do We Spend Most of Our Money On?
There has been lots written lately about the soaring cost of cancer care. You’re spending a lot on cancer recently in part because of many wonderful new treatments that come with a substantial price...
View ArticleClik here to view.
Doctors Can’t Be Trusted to Tell Patients Whether They Should Receive Robotic...
Patients often rely on physicians for information about their treatment alternatives. Unfortunately, that information is not always objective. Consider a man with early stage prostate cancer...
View ArticleClik here to view.
Out of Control Physicians: Too Many Doctors Doing Too Many Things to Too Many...
My father is 92 years old, and I am beginning to wonder whether the best thing for his health would be to stay away from doctors. That’s because well intentioned physicians often expose their elderly...
View ArticleClik here to view.
Don’t Let Your Physician Tell You What To Do Without Finding Out Your Goals
Shutterstock A recent study of men with early-stage prostate cancer found no difference in 10-year death rates, regardless of whether their doctors actively monitored the cancers for signs of growth...
View ArticleIs There a Smart Way to Use the New Oncotype Prostate Cancer Test?
On May 8th, the makers of the oncotype DX Prostate Cancer Test presented results of a large study demonstrating that their test can help men decide whether their prostate cancer carries a low enough...
View ArticleWhat Mammograms Teach Us About Wildfires, Floods, and Tornadoes
In the wake of the horrific floods that struck Colorado recently, many people have debated whether global warming is to blame. The same goes for wildfires that hit that state this summer and for the...
View ArticleYou Thought Innovation Was Hard, How about De-Innovation?
David Asch and I recently published an article in Health Affairs on the challenge of getting healthcare practitioners to stop doing things they are accustomed to doing, even when the evidence that...
View ArticleWhich Cancers Do We Spend Most of Our Money On?
There has been lots written lately about the soaring cost of cancer care. You’re spending a lot on cancer recently in part because of many wonderful new treatments that come with a substantial price...
View ArticleDoctors Can't Be Trusted to Tell Patients Whether They Should Receive Robotic...
Patients often rely on physicians for information about their treatment alternatives. Unfortunately, that information is not always objective. Consider a man with early stage prostate cancer interested...
View ArticleOut of Control Physicians: Too Many Doctors Doing Too Many Things to Too Many...
My father is 92 years old, and I am beginning to wonder whether the best thing for his health would be to stay away from doctors. That’s because well intentioned physicians often expose their elderly...
View ArticleDon't Let Your Physician Tell You What To Do Without Finding Out Your Goals
A recent study of men with early-stage prostate cancer found no difference in 10-year death rates, regardless of whether their doctors actively monitored the cancers for signs of growth or eradicated...
View Article